Transcranial Magnetic StimulationÂ
 DON'T FIGHT YOUR DEPRESSION ALONE, LET US HELP!Â
Conventional TMS Accelerated TMS
TMS for adolescents
SAINT Clinical Trial
Ketamine IV Therapy
 Open appointments for Ketamine IV
IV ketamine therapy is a revolutionary therapeutic approach to treating depression and anxiety disorders. Ketamine therapy is significantly more effective than all other pharmaceuticals, is very safe, and has no side effects. It is usually life-changing.
​
Several scientific studies, including those conducted at Yale University and the National Institute of Mental Health, have shown that low-dose intravenously administered ketamine can dramatically improve symptoms associated with depression and many anxiety disorders. Often, even when other treatments have failed to provide any relief, IV ketamine is effective.
​
All new patients have a series of six infusions spaced over two or three weeks. Each infusion is 40 minutes long, painless, and well tolerated. Most patients experience significant relief during the series, and many remain symptom-free for extended periods following the initial treatment protocol.
Ketamine therapy impacts both mood and anxiety disorders with positive treatment outcomes for the following diagnoses:
​
-
Depression, Chronic Depression, and Treatment-Resistant Depression
-
Post Traumatic Stress Disorder (PTSD)
-
Bipolar Disorder
-
Obsessive Compulsive Disorder (OCD)
-
Post Partum Depression
-
Most Anxiety Disorders
​
​
​
Call now to Make AN Appointment +1-669-696-3636
About TMS
Transcranial Magnetic Stimulation (TMS) uses a highly focused pulsed magnetic field to stimulate cortical neurons.
Targets stimulation of the left and right prefrontal cortex, and other targets as appropriate.
Modulates deeper brain regions involved in mood regulation.
Directly depolarizes cortical neurons and modulates neurotransmitter release.
Increases cerebral blood flow and glucose metabolism.
​
​
Conventional TMS, Accelerated TMS, and SAINT Clinical Trial
Non-invasive
Painless
FDA Approved
About us
Dr. Solvason
Dr. Solvason began his research in TMS in the early 2000s and subsequently served as the lead investigator at Stanford University for an international study that demonstrated the clinical effectiveness of TMS, leading to FDA approval for the treatment of treatment-resistant depression. He established and developed the TMS service at Stanford starting in 2009, successfully treating hundreds of individuals with Major Depressive Disorder (MDD).
His career has been exclusively focused on the treatment of individuals with severe Treatment-Resistant Depression (TRD). Dr. Solvason's dedication to advancing treatment options for severe TRD has been a constant feature in his career, and his innovative approach has provided hope for countless patients who have exhausted other treatment methods.
At IntegralTMS, our mission is to make Accelerated TMS financially accessible for individuals of modest means. We encourage you to compare the cost of treatment at other clinics locally, across California, and nationally. It should be noted that Accelerated TMS is not available in most TMS facilities.
Dr. Nguyen
​
Dr. Nguyen is a Bay Area native and board-certified child, adolescent, and adult psychiatrist. She completed her medical school training at UCSF followed by an adult psychiatry residency at Harvard. She returned to California for child and adolescent psychiatry fellowship at Stanford. Dr. Nguyen is a Clinical Assistant Professor at Stanford in the Department of Psychiatry and Behavioral Sciences. She specializes in working with patients and families affected by autism and other neurodevelopmental conditions.
She has worked at Integraltms along with Dr. Solvason since Jan 2020.
Testimonials
Frequently Asked Questions
